NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Arjan Gower
AD Scientific Index 2024
Medical and Health Sciences / Medical Oncology
Cedars-Sinai Medical Center - Kaliforniya / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Arjan Gower's MOST POPULAR ARTICLES
1-)
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancerA Gower, Y Wang, G GiacconeJournal of molecular medicine 92, 697-707, 2014682014
2-)
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancerA Gower, WH Hsu, ST Hsu, Y Wang, G GiacconeMolecular Oncology 10 (4), 601-609, 2016422016
3-)
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samplesTR Wilson, Y Xiao, JM Spoerke, J Fridlyand, H Koeppen, E Fuentes, ...Breast cancer research and treatment 148, 315-325, 2014402014
4-)
Novel ALK fusion, PPFIBP1-ALK, in pancreatic ductal adenocarcinoma responsive to alectinib and lorlatinibA Gower, B Golestany, J Gong, AD Singhi, AE HendifarJCO Precision Oncology 4, 2020202020
5-)
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinomaR An, Y Wang, D Voeller, A Gower, IK Kim, YW Zhang, G GiacconeOncotarget 7 (20), 29199, 2016122016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept